Amsino Medical Group Holdings Co., Ltd. – Trademark Portfolio
Entity Type: 03
Amsino Medical Group Holdings Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include EZE-VAC, RECEPTAL, VAC-GARD, IRECEPTAL, and ACCU-MEASURE. The owner is based in Pomona, CA.
708 Corporate Center Drive
Pomona, CA 917682650
Showing of trademarks Trademarks
Trademark Classifications
Amsino Medical Group Holdings Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Amsino Medical Group Holdings Co., Ltd. have?
Amsino Medical Group Holdings Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Amsino Medical Group Holdings Co., Ltd. file in?
Amsino Medical Group Holdings Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Amsino Medical Group Holdings Co., Ltd.'s most well-known trademarks?
Amsino Medical Group Holdings Co., Ltd.'s registered trademark portfolio includes well-known marks such as EZE-VAC, RECEPTAL, VAC-GARD, IRECEPTAL, and ACCU-MEASURE. These are among 6 currently registered trademarks in the portfolio.
What is Amsino Medical Group Holdings Co., Ltd.'s trademark registration success rate?
Amsino Medical Group Holdings Co., Ltd. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.